Summary
Studies on the antimetastatic activity of orally administered Lactobacillus casei (L. casei) were performed using an experimental model of hepatic metastasis. Orally administered L. casei (BLP) significantly inhibited liver tumor colonization, and lowered the incidence of hepatic metastasis the most at a dose of 100mg/kg per day. Furthermore, liver tumor colonization after inoculation with AH60C tumor cells was significantly inhibited in all the groups given BLP, particularly in the groups which were given BLP orally before tumor inoculation (P < 0.01). However, BLP had no significant effect on the rate of incidence of hepatic metastasis. These results strongly suggest that L. casei has an antimetastatic effect, and that it may be of therapeutic use for the prevention of micrometastasis after surgery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kasagi T, Tazawa K, Nagase T, Sawataishi M, Karaki Y, Maeda M, Honda T, Fujimaki M (1983) Inhibition of hepatic micro-metastasis for prophylactic cancer therapy. In: Proceedings of the 42nd annual meeting of the Japanese Cancer Association, p 442
Tazawa K, Kasagi T, Nagase T, Sawataishi M, Masuyama K, Takemori S, Yoshida M, Suzuki Y, Fujimaki M, Maeda M, Honda T (1987) Serum levels, especially in the portal vein, of 99m-Tc-labeled OK-432-MCT emulsion administered enterally. Excerpta Medica, Tokyo, pp 240–248
Kawagoshi T, Yamashita I, Maeda M, Masuyama K, Yoshida M, Suzuki Y, Kasagi T, Tazawa K, Fujimaki M, Ochiai H, Honda T (1988) Proceedings of the 47th annual meeting of the Japanese Cancer Association, p 615
Kasagi T, Tazawa K, Yamashita I, Ishizawa S, Masuyama K, Fujimaki M, Maeda M (1990) The prophylactic therapy for liver metastasis of gastro-intestinal carcinomas using biological response modifier (BRM): fundamental studies on the inhibition of experimental liver metastasis by intraportal administration of OK-432. J Jpn Soc Cancer Ther 25(1):112–120
Perdigon G, Alvarez S, De Macias MEN, Margni M, Oliver G, De Ruiz Holgado AAP (1986) Lactobacilli administered orally induce release of enzymes from peritoneal macrophages in mice. Milchwissenschaft 41:344–348
Perdigon G, De Macias MEN, Ivarez S, Medici M, Oliver G, De Ruiz Holgado AAP (1986) Effect of a mixture of Lactobacillus casci and Lactobacillus acidophilus administered orally on the immune system in mice. J Food Protect 49:986–989
Perdigon G, De Macias MEN, Alvarez S, Oliver G, De Ruiz Holgado AAP (1986) Effect of perorally administered lactobacillus on macrophage activation in mice. Infect Immunol 53:404–410
Aso Y, Akaza H (1992) The BLP Study Group: Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. Urol Int 49:125–129
Kato I, Yokokura T, Mutai M (1985) Induction of tumoricidal peritoneal exudate cells by administration of Lactobacillus casei in mice. Int J Immunopharmacol 7:103–109
Matsuzaki T, Yokokura T, Azuma I (1987) Antimetastatic effect of Lactobacillus casei YIT 9018 (LC9018) on a highly metastatic variant of B16 melanoma in C57BL6J mice. Cancer Immunol Immunother 24:99–105
Nomoto K, Miake S, Hashimoto S, Yokokura T, Mutai M (1985) Augmentation of host resistance to Listeria monocytogene infection by Lactobacillus casei in mice. J Clin Lab Immunol 17:91–97
Matsuzaki T, Yokokura T (1989) Antitumor effect of oral administration of Lactobacillus casei in newborn mice (in Japanese). Igaku no Ayumi (J Clin Exper Med) 150:745–746
Kato I, Yokokura T, Mutai M (1988) Correlation between increase in la-bearing macrophages and induction of T-cell-dependent antitumor activity by Lactobacillus casei in mice. Cancer Immunol Immunother 26:215–221
Kato I, Yokokura T, Mutai M (1981) Macrophage activation by Lactobacillus casei in mice. Microbiol Immunol 27:611–618
Kato I, Kobayashi S, Yokokura T, Mutai M (1981) Antitumor effect of Lactobacillus casei in mice. Gann (Cancer) 72:517–523
Kato I, Yokokura T, Mutai M (1984) Augmentation of mouse natural killer cell activity by Lactobacillus casei and its surface antigens. Microbiol Immunol 28:209–217
Yasutake N, Kato I, Ohwaki M, Yokokura T, Mutai M (1984) Hostmediated antitumor activity of Lactobacillus casei in mice. Gann (Cancer) 75:72–80
Kato I, Endo K, Yokokura T (1992) Induction of antitumor activity with oral administration of Lactobacillus casei in mice (in Japanese). Biotherapy 6:1121–1126
Kato I, Endo K, Yokokura T (1994) Effect of oral administration of Lactobacillus casei on antitumor responses induced by tumor resection in mice. Int J Immunopharmacol 16(l):29–36
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Japan
About this paper
Cite this paper
Tazawa, K. et al. (1997). Intestinal Flora and Cancer Control: Inhibitory Effect of Oral Administration of Lactobacillus casei in a Model of Hepatic Metastasis of Rat. In: Ohigashi, H., Osawa, T., Terao, J., Watanabe, S., Yoshikawa, T. (eds) Food Factors for Cancer Prevention. Springer, Tokyo. https://doi.org/10.1007/978-4-431-67017-9_72
Download citation
DOI: https://doi.org/10.1007/978-4-431-67017-9_72
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-67019-3
Online ISBN: 978-4-431-67017-9
eBook Packages: Springer Book Archive